No images? Click here
From the leadership
Professors Robyn Norton and Stephen MacMahon, Co-founders and Principal Directors, The George Institute for Global Health
It’s been more than 20 years since we founded The George Institute for Global Health. And what a great honour and privilege to have grown and led the Institute from three people in one room with a bold mission, to the global organisation it is today, with more than 1,000 people across four regional offices. For over 20 years, our teams have been transforming clinical guidelines, delivering affordable, innovative healthcare solutions, and helping to create healthier societies.
We are extremely proud of our collective achievements to date, however there is so much more that remains to be done. But we believe it is time for new leadership to usher the Institute into its next phase of growth and impact. And so it is for this reason, that at the end of this year, we plan to step down from our roles as Principal Directors.
This has, by no means, been an easy decision for us. But we believe the time is right. The George Institute has never been in a stronger position – both financially and in the quality and quantity of its research and impact. A fresh vision and new ideas, though, have the potential to take the Institute to even greater levels of success and we are both very much committed to supporting the successful transition to a new Principal Director.
Meanwhile, our teams have continued to push new boundaries these past few months and we are excited to present a recap of some of our work since the beginning of 2022. We hope you enjoy reading about it!
Latest news
Imperial and The George Institute renew collaboration
Following a successful initial collaboration in 2020, a new five-year commitment has been agreed between Imperial College London and The George Institute.
New funding for better heart health in Aboriginal and Torres Strait Islander communities
The George Institute is part of the Australian Government’s Medical Research Future Fund commitment to establish new research centres for diabetes and cardiovascular disease.
First-ever trial to study effectiveness of traditional Chinese medicine on stroke recovery
This first large high-quality clinical trial to assess the effects of traditional Chinese medicine in patients who have suffered a stroke has successfully completed the first stage of set-up across 15 centres in China.
Latest research
People living with dementia at risk from rising temperatures
As climate change pushes up temperatures, the UK can expect increased emergency dementia admissions, finds a collaborative study by The George Institute and Centre on Climate Change and Planetary Health at the London School of Hygiene and Tropical Medicine.
Time to shift research focus from ‘bikini medicine’ to what is really ailing women
Women’s health research remains disproportionately focused on the reproductive years - particularly on pregnancy – with few articles on the major causes of illness and death in women.
One in two patients across ICUs in India suffers from sepsis
The ‘Sepsis in India Prevalence Study’ shows the alarming burden of this life-threatening disease among critical care patients in Indian hospitals.
First direct evidence to show cost-effectiveness of salt substitutes on cardiovascular outcomes
A China-based study shows that the costs saved by replacing salt outweighed the cost of the intervention, providing evidence for the scale-up of salt substitution.
COVID-19 clinical trials disproportionately run out of high-income countries
New research has shown that COVID-19 clinical trials are being disproportionately run out of high-income countries.
News and opinion
Tracking laws that govern the determinants of health: some reflections on why and how
Kent Buse, Director, Healthier Societies Program, and Devaki Nambiar, Program Head, Health Systems and Equity, call for a ‘World Wellbeing Watch’ in a new blog.
Why periods, pregnancy and menopause might affect the risk of dementia
PhD candidate Jessica Gong talks to the Sydney Morning Herald about her latest study on how reproductive events in a woman’s life impact her dementia risk.
Dr Christine Jenkins, Head of the Respiratory Group at The George Institute, talks to ABC News about what the pandemic could look like in Australia this year.
Concerned about your risk of a heart attack? Here are 5 ways to improve your heart health
Senior Research Fellow Ellie Paige and colleagues write a piece in The Conversation in the wake of former Australian cricketer Shane Warne’s death on how to take better care of one’s heart.
Impact: reports and submissions
Heralding a new era in kidney disease research and treatment: CREDENCE trial
The landmark clinical trial, CREDENCE, transformed the status quo in diabetic kidney disease research by identifying the first new treatment in almost 20 years, paving the way for changes in treatment guidelines and practice worldwide.
The potential impact of salt reduction in Fiji
The report led by Jacqui Webster, Head of Advocacy and Policy Impact, assessed the potential benefits of implementing a national salt reduction program in Fiji to prevent stroke and cardiovascular events, and reduce healthcare needs, informal care and productivity costs.
Engage with us
The NCD Lab on Women and Girls, co-chaired by WHO and The George Institute for Global Health, supports innovative, ambitious initiatives that promote gender equity and progress among women and girls towards SDG target 3.4: to reduce by one-third premature mortality from NCDs, and promote mental health and wellbeing.
The third cycle of the NCD Lab is now open and inviting submissions that respond to 'tackling obesity through innovation and global action'. Entries welcome until 30th June 2022.
